Why Sponsor Eye Believe? Your sponsorship is more than a logo—it’s a lifeline. Eye Believe is one of the few nationwide events dedicated exclusively to patients living with ocular melanoma. It offers medical insight, emotional strength, and a renewed outlook on life. By partnering with us, you help ensure this event remains accessible to all, [...]
2025 Rare Disease Day, Hill Day and MRA Scientific Meeting
A Cure In Sight celebrated rare disease week in Washington DC and Boston MA. We had a great group of ocular melanoma patients and supports join ACIS and Everylife Foundation for a great 2 days at Capital Hill. In person meetings were held with Representatives and Senators from Rhode Island, Virginia, Pennsylvania, North Carolina [...]
Faces of ocular melanoma 2025
Your Content Goes Here
Meet Arjun Pediatric Ocular Melanoma Survivor
Meet Arjun, Pediatric Ocular Melanoma Arjun was diagnosed as a baby with #ocularmelanoma making him one of the rarest in our rare cancer community. When asked what the hardest parts of navigating a pediatric cancer diagnosis as a family was, his mother Sumathy shared: "I find I struggle with having a child with cancer. [...]
Novel Replimune RP2 Treatment for Metastatic Uveal Melanoma
Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research Replimune Presents Updated Data on RP2 in Uveal Melanoma RP2 as monotherapy and in combination with nivolumab showed a favorable safety profile and durable responses in nearly 30 percent of [...]
FDA Approved Liver-Directed Therapy Update
FDA Approved Liver-Directed Treatment for Metastatic Ocular Melanoma Patients Delcath Systems announces a new locator on their treatment page for liver-directed treatment of metastatic ocular melanoma. Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) Check this out and share with metastatic #ocularmelanoma patients. Please especially share the news if [...]
Clinical Trial Metastatic Ocular Melanoma
Novel Metastatic Treatment for Metastatic Ocular Melanoma Patients Looking for treatment options for metastatic ocular melanoma? IDEAYA BIOSCIENCES is currently enrolling patients in multiple arms for their clinical trials for metastatic ocular melanoma, as well as front line treatments. Check out their website, https://www.ideayabio.com/ for information on their enrolling trials. Additionally, you can [...]
Rare Disease Day – Ocular Melanoma Stories
Celebrating Life Beyond Ocular Melanoma: Tricia's 19-Year Journey In the spring of 2005, Tricia's routine eye examination uncovered something life-altering. At 46, a day that began with the simple intent to get reading glasses led to a diagnosis of ocular melanoma. Facing the unknown with her family by her side, Tricia's resilience shone [...]
Melanoma Exchange Patient Forum 2024
A Cure in Sight attends the Melanoma Patient Exchange Forum, hosted by Melanoma research Alliance Washington DC, February 22, 2024—A Cure in Sight Ocular Melanoma has been in attendance at the Melanoma Exchange Patient Forum this week to advocate for awareness for ocular melanoma. This event is hosted by the Melanoma Research Alliance. [...]
ACIS Announces New Director of Community Engagement
ACIS announces new Director of Community Engagement: Jennifer Hoke to join ACIS’s growing team January 15 Raleigh, NC., January 15, 2024—A Cure in Sight Ocular Melanoma, today announced that they have expanded their Non-Profit foundation by hiring Jennifer Hoke as the Director of Community Engagement. Jennifer will be coordinating ACIS sponsored communications and [...]